- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
Find out via the online I-Corps@NCATS National Bootcamp. Based on the National Science Foundation’s Innovation Corps (I-Corps™) program, the premier federally-funded innovation and commercialization training program in the U.S., I-Corps@NCATS provides biomedical scientists and clinicians with a new approach to accelerate the translation of discoveries from the lab to clinical practice. WHO: Teams
2023 BDSIL: Data Science and the Public Health Consequences of the COVID-19 Pandemic June 26-30, 2023 • Kenmore, Washington Applications due January 29, 2023 at 11:59 PM ET Join us for the 2023 BDSIL: a unique hybrid program consisting of online team-building activities and a series of scientific presentations that lead-up to an all-expenses-paid, 5-day in-person intensive workshop at The Lodge at
APPLICATIONS DUE January 8th The global COVID-19 pandemic over the past two years has upset our lives in ways unimaginable before we took to wearing masks, isolating at home, and avoiding contact with family, friends, and colleagues. We are only now, just contending with the secondary effects of COVID exposures – so-called ‘long-haul COVID’ – but also the effects of deferred regular health check
Bidirectional Partnerships: Moving at the Speed of Trust to Speed Innovation: Yale School of Medicine (YSM) and its Yale Center for Clinical Investigation (YCCI), the administrative home of the Yale CTSA, has had great success advancing health and research equity through the science of translation and collaboration, including: Addressing community health equity and capacity building with the
Digital technology can enable trial participation via an internet portal or smartphone app, eConsent, data collection directly via wearables and smartphones, ecologic momentary assessment, and other trial innovations. The Eureka Research Platform, a digital platform funded by NIH and housed at UCSF, supports digital trials and prospective data collection for funded researchers across the US
Researchers are working to better prepare for the next pandemic. One of those researchers is Kevin Messacar, MD, PhD, an infectious disease expert and physician at Children’s Hospital Colorado and associate professor at the University of Colorado Anschutz Medical Campus. Messacar is leading an innovative, nationwide pilot study focusing on enterovirus D68, a virus that is linked to a rare polio
The dissemination of the I-Corps@NCATS program has accelerated the development and commercialization of breakthrough innovations in medical research across U. Miami and the CTSA partner hubs. Taking the lessons from the “I-Corps at the CTSA Train-The-Trainer pilot initiative” in 2017, nine participants developed the I-Corps@NCATS program with support from a CTSA Administrative Supplement to
Daniel Benjamin, MD, PhD, MPH1; Gordon R. Bernard, MD2; J. Michael Dean, MD, MBA3; Daniel E. Ford, MD, MPH4; Daniel Hanley, MD4; Paul A. Harris, PhD, FACMI2; Harry Selker, MD, MSPH5; Consuelo H. Wilkins, MD, MSCI2 1Duke Clinical Research Institute, 2Vanderbilt Institute for Clinical and Translational Research, 3University of Utah, 4Johns Hopkins University, 5Tufts University ABSTRACT: The Trial
True innovation depends on identifying the right problem to solve. To streamline the process of identifying opportunities for innovation, FastTraCS has developed a virtual, scalable approach to rapidly identifying impactful clinical problems—creating a foundation for unmet need definition, validation and new product development. This approach eliminates the need for upfront clinical shadowing/
The Catalyze Program, established by NHLBI and run by Research Triangle Institute (RTI) International, transforms basic science discoveries into viable therapeutics, devices, and diagnostics. While the actual Catalyze Program is focused on products for heart, lung, blood, and sleep disorders, the information presented in these monthly seminars is foundational knowledge about product development
The CCTSI responded to the pandemic by issuing a rapid-release RFA to address COVID-19. CCTSI leaders called it the COVID-19-Rapid Research Pilot Program. They released the RFA on Monday evening, March 30 and closed the application process just four days later. This new pilot grant program supported the development of novel diagnostic and treatment methods and innovative technologies related to
The recipients of NIH Clinical and Translational Science Awards (CTSA) have worked for over a decade to build informatics infrastructure in support of clinical and translational research.
The UC Davis CTSC applied the CTSA program goals to assist the division of pulmonary and sleep medicine with the recruitment, examination, and treatment of a diverse array of participants into an industry-funded COVID-19 vaccine trial. The project encompassed all five of the CTSA program goals and resulted in a robust study population. The first 80 subjects were recruited, screened, and scheduled